QUOTED. April 17, 2019. Gioia Althoff.
SOPHiA GENETICS received the CE-IVD mark for its molecular diagnostic device, Solid Tumor Solution (STS). See what the company's genomics senior VP, Gioia Althoff, said about it here.
"We are currently growing our presence in the US with the hiring of talent that understand the challenges of Data-Driven Medicine adoption in order to serve the medical community the best way we can and meet the demand we face from health-care institutions in the region." –Gioia Althoff, genomics senior VP, SOPHiA GENETICS
Click here for a free trial of Medtech Insight